Navigation Links
Results Reported for Exploratory Phase 2 Study of Nexavar in Combination With Chemotherapeutic Agent Paclitaxel for Treatment of Advanced Breast Cancer
Date:9/29/2009

WAYNE, N.J. and EMERYVILLE, Calif., Sept. 30 /PRNewswire-FirstCall/ -- Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced results from a randomized, placebo-controlled Phase 2 trial sponsored by Northwestern University. The study, which evaluated Nexavar® (sorafenib) tablets in combination with the chemotherapeutic agent, paclitaxel, in patients with locally advanced or metastatic HER-2 negative breast cancer, demonstrated a positive trend towards improvement of progression-free survival in the treatment group (p-value=0.09). The safety and tolerability profile of the combination was consistent with the previous experience with each agent and no new toxicities were observed.

A complete data analysis from this study is expected to be presented at an upcoming scientific meeting. Patients are continuing to be followed for a secondary endpoint of overall survival.

The trial was led by principle investigator William Gradishar, M.D., professor of medicine, Robert H. Lurie Comprehensive Cancer Center of Northwestern University. "These encouraging data warrant further investigation to determine the potential of the Nexavar and paclitaxel treatment combination in patients with advanced breast cancer, an often underserved patient population," said Dr. Gradishar.

"The preliminary results in this study demonstrate a clinical signal in favor of this treatment combination. These data require further analysis and interpretation before we determine the appropriate path forward," said Todd Yancey, M.D., vice president of clinical development at Onyx. "This trial is the second of four from our comprehensive clinical program in breast cancer, which is intended to explore Nexavar's utility in a number of disease settings."

Bayer and Onyx recently reported statistically sig
'/>"/>

Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Docs Miss Test Results -- Even With Alerts
2. Results From Landmark PROSPECT Trial Demonstrate the Ability of Volcanos VH(R) IVUS Imaging to Identify Plaques Most Likely to Cause Heart Attacks
3. Video: New Clinical Trial Results Show Germ-Killing Action of LISTERINE(R) Antiseptic Kills Germs in the Mouth Before They Travel to the Bloodstream
4. Volcano Corporation Praises FAME Study Results
5. Dynatronics to Release Fourth Quarter and Year-end Results Friday, September 25, 2009; Conference Call Set for 12:30 p.m. ET
6. InVitria Presents Zap-CHO Performance Results at PEACe Conference
7. Natural Alternatives International, Inc. Announces Fiscal 2009 Q4 and Full Year Results
8. Assurant to Announce 2009 Third Quarter Results Oct. 28, 2009 and Host Webcast Conference Call Oct. 29
9. SpectraScience Announces Results of Annual Shareholder Meeting
10. One-year results from Horizons-AMI trial reported at TCT 2009
11. New type of sirolimus-eluting stent demonstrates superior results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... With recent headlines about the kidnapping of Bossini ... men from Southern China, it is becoming apparent to people ... for them. This is especially true for High Net Worth ... attention through the property they own, the schools their children ... those individuals, families and companies that are at higher risk ...
(Date:5/6/2015)... The dates have been selected and ... Changers Summit 2015 , an Information & Technology for ... Communications. Join the international gathering September 17-19 at the ... leaders from around the globe will speak and train ... the developing world. , The theme of the two-and-a-half-day ...
(Date:5/6/2015)... With an estimated 300,000 New Jersey ... potentially dangerous health effects, the Horizon Foundation of New ... Easier with Asthma Management) – to improve awareness, education ... through a $500,000 foundation grant to the Boys & ... BEAM throughout the state. , “While asthma cannot be ...
(Date:5/6/2015)... RPS Revolution - a game for the whole family with ... Scissors game - is now taking pre-orders via Kickstarter. ... to learn rules from Rock Paper Scissors, families can now ... Revolution takes the best parts of Rock Paper Scissors ... set of three called Trios. Trios like a Knight, Princess, ...
(Date:5/6/2015)... exclusive hospital of the Tampa Bay Buccaneers, Florida Hospital hosted ... Stadium for all the “Bucs Babies” celebrating their first birthday. ... “Bucs Babies” program last year. , “It is always ... born at the Florida Hospitals here in our community, who ... my time participating in the festivities, interacting with the Bucs ...
Breaking Medicine News(10 mins):Health News:Pacific Prime China Now Offering Kidnapping & Ransom Insurance 2Health News:Second Annual Game Changers Summit Offers ICT4D Workshops to 'Harness Power of Technology for Global Good' 2Health News:Second Annual Game Changers Summit Offers ICT4D Workshops to 'Harness Power of Technology for Global Good' 3Health News:The Horizon Foundation for New Jersey and Boys & Girls Clubs in New Jersey Join Forces to Help Children with Asthma 2Health News:The Horizon Foundation for New Jersey and Boys & Girls Clubs in New Jersey Join Forces to Help Children with Asthma 3Health News:The Horizon Foundation for New Jersey and Boys & Girls Clubs in New Jersey Join Forces to Help Children with Asthma 4Health News:RPS Revolution Launches Kickstarter Campaign 2Health News:RPS Revolution Launches Kickstarter Campaign 3Health News:Florida Hospital and the Tampa Bay Buccaneers Celebrate “Bucs Babies” Who are Turning One this Month with a Party on the Pirate Ship 2Health News:Florida Hospital and the Tampa Bay Buccaneers Celebrate “Bucs Babies” Who are Turning One this Month with a Party on the Pirate Ship 3
... University of Wisconsin-Madison Center of Excellence in Cancer Communication ... the online information services and the information provided by ... coming to terms with it. ,Breast cancer ... computer support groups and other interactive services are the ...
... to anthrax being confirmed from Koothattukulam in Ernakulam district, the ... of the disease.// ,Tests conducted on the samples ... died a few days back had confirmed that the cause ... department said., ,The tests were conducted at the Avian ...
... Annual Meeting of SNM in San Diego witnessed a ... molecular imaging and nuclear medicine branch// and this meeting ... days. ,“SNM continues to successfully offer a ... on new and evolving aspects of nuclear medicine and ...
... researchers led by Dr. Adam Godzik at the Burnham ... up the understanding of information gathered// from the human ... them over a three year period, this consortium, under ... to provide adequate support to scientists from Burnham and ...
... Atlantic University, the Center for Breast Care at the ... The Center for Diagnostic// Systems and Visualization at the ... aid clinicians in the diagnosis and treatment of breast ... a unique software platform utilizing computational clinical imaging techniques ...
... from the University of South Florida has reported that nicotine ... ,They explained in the August issue of the ... that cause cancer, and that nicotine itself isn't one of ... existing cancer cells. ,The new study has explained ...
Cached Medicine News:Health News:Cancer patients benefited by online information services and support groups 2Health News:SNM recognizes exemplary contributors in nuclear medicine 2Health News:Joint Center for Molecular Modeling Instituted by Burnham Institute for Medical Research & UC San Diego 2Health News:New Tool to Diagnose and Treat Breast Cancer 2Health News:New Tool to Diagnose and Treat Breast Cancer 3Health News:Research Finds That Nicotine Hastens The Growth Of Lung Cancer 2
(Date:5/6/2015)... -- Zimmer Holdings, Inc. (NYSE and SIX: ZMH), a global leader ... at the Bank of America Merrill Lynch 2015 Health Care ... Vegas, Nevada on Wednesday, May 13, at 8 ... the presentation can be accessed via Zimmer,s Investor Relations website ... replay following the conference. About the Company Founded ...
(Date:5/6/2015)... YORK , May 6, 2015  The fairness ... or the "Company") by Alexion Pharmaceuticals, Inc. ("Alexion") is ... shareholder rights law firm, for possible breaches of fiduciary ... of Directors of GEVA for agreeing to sell the ... announced a definitive agreement for Alexion to acquire GEVA ...
(Date:5/6/2015)... 2015 China Biologic Products, Inc. (NASDAQ: CBPO, ... plasma-based biopharmaceutical company in China, today announced its unaudited ... First Quarter 2015 Financial Highlights ... increased by 25.0% to $70.4 million from $56.3 million ... profit increased by 18.9% to $45.9 million from $38.6 ...
Breaking Medicine Technology:WeissLaw LLP Investigates the Synageva Biopharma Corp. Acquisition 2China Biologic Reports Financial Results for the First Quarter of 2015 2China Biologic Reports Financial Results for the First Quarter of 2015 3China Biologic Reports Financial Results for the First Quarter of 2015 4China Biologic Reports Financial Results for the First Quarter of 2015 5China Biologic Reports Financial Results for the First Quarter of 2015 6China Biologic Reports Financial Results for the First Quarter of 2015 7China Biologic Reports Financial Results for the First Quarter of 2015 8China Biologic Reports Financial Results for the First Quarter of 2015 9China Biologic Reports Financial Results for the First Quarter of 2015 10China Biologic Reports Financial Results for the First Quarter of 2015 11China Biologic Reports Financial Results for the First Quarter of 2015 12China Biologic Reports Financial Results for the First Quarter of 2015 13China Biologic Reports Financial Results for the First Quarter of 2015 14China Biologic Reports Financial Results for the First Quarter of 2015 15China Biologic Reports Financial Results for the First Quarter of 2015 16China Biologic Reports Financial Results for the First Quarter of 2015 17China Biologic Reports Financial Results for the First Quarter of 2015 18
... many injections, in two pivotal Phase 3 trials, ... of sustained virologic response comparable to Pegasys (peginterferon ... comparable rates of serious and/or severe adverse events ... alfa-2a -- Submission of global marketing applications planned ...
... for the treatment of type 2 diabetesHAYWARD, Calif., April ... of patient accrual to a phase 1b clinical study ... study is being conducted at multiple centers in the ... with type 2 diabetes for a period of 4 ...
Cached Medicine Technology:Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C 2Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C 3Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C 4Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C 5Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C 6Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C 7Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C 8Intarcia Therapeutics, Inc. Announces Completion of Enrollment of ITCA 650 Phase 1b Study for the Treatment of Type 2 Diabetes 2Intarcia Therapeutics, Inc. Announces Completion of Enrollment of ITCA 650 Phase 1b Study for the Treatment of Type 2 Diabetes 3
... to block tear drainage through the canaliculus, synthetic ... eye symptoms:, Indicated for use in the ... eye components of various ocular surface diseases, May ... eye related complications and to enhance the retention ...
... Inserted into the punctal opening to block ... provide long-term relief of dry eye symptoms, ... of its own natural tears:, Low-profile ... Flexibility of cap design facilitates easy removal ...
... The distinctive low profile dome head combined ... patient comfort. The pointed nose design simplifies ... shelf firmly secures plug making dislocation less ... and eliminates premature plug release. SOFT PLUG ...
... Flow Controllers may be used ... too much. The tapered shaft ... vector force, keeping it snugly ... it can be monitored. Designed ...
Medicine Products: